http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104721194-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
filingDate 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc9613789c35ff3b409910828d6498cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6719bdc3539ebadeb0d18fa03da0ac3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719b0310d7da41ad2fcd37b6576318a2
publicationDate 2015-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104721194-A
titleOfInvention Application of O-(1H-tetrazolyl)ethyl derivatives of cleorinone in the preparation of anti-inflammatory drugs
abstract The invention relates to the fields of organic synthesis and medicinal chemistry, in particular to O-(1H-tetrazolyl)ethyl derivatives of cleistanone, a preparation method and an application in the preparation of anti-inflammatory drugs. The present invention synthesizes a new O-(1H-tetrazolyl)ethyl derivative of Cleistanone, and discloses its preparation method. Pharmacological experiments show that the O-(1H-tetrazolyl)ethyl derivative of Cleistanone of the present invention has an anti-inflammatory effect, and has the value of developing anti-inflammatory drugs.
priorityDate 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465168574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152867847

Total number of triples: 15.